Financial terms of the deal were not disclosed.
Rebound touts its Aurora Surgiscope system, — cleared by FDA in January — as the first single-use disposable neurosurgical endoscope. The Aurora system enables minimally invasive access, visualization and illumination during neurosurgical procedures.
“Rebound’s MIS technological platform is a natural addition to our portfolio of neurosurgical products and will expand our therapeutic-focused offerings. We are eager to further develop Rebound’s cutting-edge MIS technologies to help surgeons improve the standard of care for neurosurgery patients,” Dan Reuvers, corporate CP and president of Integra LifeSciences’ Codman Specialty Surgical division, said in a news release.
Integra LifeSciences does not expect a material financial impact from the acquisition in 2019.